what happens when astrocytes are damaged

Astrocytes are less vulnerable than neurons to ischemic injury but they are damaged if there is lactic acidosis. Such damage causes intracellular fluid accumulation (cytotoxic edema). Cytotoxic edema involves the cerebral cortex, whereas vasogenic edema is more pronounced in the white matter.

Full Answer

How do astrocytes contribute to neurodegenerative diseases?

Jan 12, 2020 · What happens when astrocytes are damaged? Astrocytes are less vulnerable than neurons to ischemic injury but they are damaged if there is lactic acidosis. Such damage causes intracellular fluid accumulation (cytotoxic edema). Cytotoxic edema involves the cerebral cortex, whereas vasogenic edema is more pronounced in the white matter.

What is an example of astrocyte dysfunction?

When neurons are lost and brain tissue is damaged from whatever cause, astrocytes proliferate, fill the gaps, and restore CSF-brain and blood-brain barriers. This process, which is called astrogliosis or plain gliosis , involves proliferation and hypertrophy of astrocytes and upregulation of GFAP expression, and is for the CNS what scarring is for extraneural tissues.

What is the anatomy of astrocytes?

May 01, 2012 · Abstract. Astrocytes are no longer seen as a homogenous population of cells. In fact, recent studies indicate that astrocytes are morphologically and functionally diverse and play critical roles in neurodevelopmental diseases such as …

What is the astrocyte-neuron problem?

Jan 15, 2010 · Reactive astrogliosis starts when trigger molecules produced at the injury site drive astrocytes to leave their quiescent state and become activated. Distinctive morphological and biochemical features characterize this process (cell hypertrophy, upregulation of intermediate filaments, and increased cell proliferation).

What would happen without astrocytes?

Summary: Pretty much everything happening in the brain would fail without astrocytes. These star-shaped glia cells are known to have a critical role in synapse creation, nervous tissue repair, and the formation of the blood-brain barrier.Dec 10, 2015

What are astrocytes responsible for?

The broad role of astrocytes is to maintain brain homeostasis and neuronal metabolism. It's hypothesized that the “star-shape” supports the neurons and creates the microarchitecture of the brain parenchyma illustrating that form-follows-function rule seen across biology.May 13, 2016

What is astrocyte dysfunction?

Dysfunctional Astrocytes Contribute to Neuronal Toxicity. Astrocyte dysfunction elicits neuronal toxicity via five main mechanisms. (A) Aquaporin-4 (AQP4) water channels are mislocalised away from the astrocyte end-feet, resulting in impaired water transport.

Do astrocytes respond to injury?

In addition to upholding normal brain activities, astrocytes respond to diverse forms of brain injury with heterogeneous and progressive changes of gene expression, morphology, proliferative capacity and function that are collectively referred to as reactive astrogliosis.Mar 28, 2015

What happens when astrocytes are activated?

Another major function of these astrocytes involves their activation in response to damage. Astrocyte activation, or astrogliosis, plays a central role in the response to most or all neurological insults including trauma, infections, stroke, tumorigenesis, neurodegeneration, and epilepsy.Jul 7, 2014

How do astrocytes affect neurons?

Astrocytes outnumber neurons in the human brain, and they play a key role in numerous functions within the central nervous system (CNS), including glutamate, ion (i.e., Ca2+, K+) and water homeostasis, defense against oxidative/nitrosative stress, energy storage, mitochondria biogenesis, scar formation, tissue repair ...May 5, 2019

What would happen if astrocytes were destroyed or become dysfunctional?

Dysfunction of astrocytes can thereby induce major alterations in neuronal functions, contributing to the pathogenesis of several brain disorders.

What is the astrocyte?

Astrocytes are specialized glial cells that outnumber neurons by over fivefold. They contiguously tile the entire central nervous system (CNS) and exert many essential complex functions in the healthy CNS.

Do astrocytes form myelin sheath?

Astrocytes Provide Lipids for Myelin Sheath Production Still consistent with their implication in myelination, astrocytes were also proposed to supply lactate to oligodendrocytes. Lactate constitutes a source of energy and a precursor of lipid synthesis including cholesterol altogether necessary for myelin production.Apr 7, 2020

Do astrocytes guide neuron development?

Astrocytes constitute the majority of glial cells in the CNS. Astrocyte-derived factors have essential effects to promote neuronal development. Wnt3 released by astrocytes regulate neural stem cell differentiation through Wnt/β-catenin signal pathways (Kuwabara et al., 2009).

How does the brain respond to injury?

When the brain is damaged by trauma or ischemia (restriction in blood supply), immune cells such as macrophages and lymphocytes dispose of the damaged neurons with an inflammatory response. However, an excessive inflammatory response can also harm healthy neurons.Dec 15, 2016

Where do astrocytes come from?

Astrocytes are derived from heterogeneous populations of progenitor cells in the neuroepithelium of the developing central nervous system. There is remarkable similarity between the well known genetic mechanisms that specify the lineage of diverse neuron subtypes and that of macroglial cells.

How do astrocytes help the brain?

Astrocytes also improve communications between brain cells and regulate the metabolic processes within the brain.

What are the roles of astrocytes in the brain?

Astrocytes contribute to the production and maintenance of the blood-brain barrier. The blood-brain barrier is a semi-permeable membrane that prevents certain components of the blood from passing out of circulation into the extracellular fluid of the central nervous system.

What are the synapses of astrocytes?

Similarly to other neuronal cells, astrocytes are comprised of synapses, or cell ends that allow for chemical and electrical communication between cells. Astrocytes also consist of dendrites that allow for communications from other cells to be transmitted within the cell body of the astrocyte. There are two major types of astrocytes, called ...

What is the grey matter in the brain?

The grey matter in the brain controls functions such as muscle control and sensory perception, including speech , taste, sense of smell, memory, judgment, and more. Fibrous astrocytes are found throughout the white matter in the brain, which is where insulated nerve fibers are present.

What are the metabolic processes of the brain?

Metabolic processes within the brain include the removal of waste products and the processing of substances used for cellular energy. While astrocytes play an integral role in repairing damage to the brain, their structure and function also lend them to a less helpful purpose.

What is the treatment for GFAP astrocytopathy?

Treatment of new cases of GFAP astrocytopathy consists of high doses of corticosteroids and immunoglobulin, which is a formula of proteins that boost the immune system. In this instance, immunoglobulin is provided intravenously, or via infusion through the arm.

Who is Brittany Ferri?

Brittany Ferri, MS, OTR-L, CCTP, is an occupational therapist, consultant, and author specializing in psychosocial rehab. Nicholas R. Metrus, MD, is a board-certified neurologist and neuro-oncologist.

What are astrocytes? What are their functions?

Astrocytes are key active elements of the brain that contribute to information processing. They not only provide neurons with metabolic and structural support, but also regulate neurogenesis and brain wiring. Furthermore, astrocytes modulate synaptic activity and plasticity in part by controlling the extracellular space volume, ...

What is the role of astrocytes in the brain?

Many studies have shown their contribution to information processing and memory formation in the brain, thereby pointing to a role of astrocytes in higher integrated brain functions. Dynamic bidirectional signalling between astrocytes and neurons has mainly been reported in experimental animal models.

Where is glutamate elevated?

Extracellular glutamate concentration is elevated in tumoural and peritumoural regions, especially close to tumours containing necrotic areas in high-grade astrocytoma patients ( Roslin et al., 2003 ). Similar results have also been observed in oligodendrogliomas, which present high levels of glutamate and glutamine in the peritumoural area, as assessed by magnetic resonance spectroscopy ( Rijpkema et al., 2003 ). This altered glutamate homeostasis explains why during the time course of the disease, 60–80% of glioma patients experience seizures ( Kurzwelly et al., 2010, Lynam et al., 2007 ), which originate close to the tumour mass ( Pallud et al., 2013, Patt et al., 2000 ). Various studies aiming at identifying the source of peritumoural glutamate reported an impaired expression of glutamate transporters on glioma cells: brain tissues from glioblastoma patients indeed display a strong reduction in GLT-1 levels, while GLAST is normally expressed but is thought to be mislocalized in cell nuclei rather than at the plasma membrane ( Lynam et al., 2007, Savaskan et al., 2008, Ye et al., 1999 ). Decreased GLT-1 levels have also been observed in high-grade compared to low-grade astrocytomas and normal brains ( de Groot et al., 2005 ). Furthermore these changes are accompanied by an altered expression of the cysteine-glutamate system (xc system), a Na + -independent exchanger that controls the intracellular glutathione levels by importing one molecule of extracellular cysteine (required in glutathione synthesis) per released glutamate. Glioma cell lines originated from tumours and brain specimens from glioblastoma patients express the xc system at significantly higher levels compared to human tissue samples without malignant transformation ( Savaskan et al., 2008, Ye et al., 1999 ). Furthermore, a recent study has shown that 50% of patient-derived gliomas have elevated expression of SLC7A11, the catalytic subunit of the xc system responsible for xc-mediated glutamate release ( Robert et al., 2015 ). Interestingly, when these glioma cells implanted intracranially in mice propagated in vivo as flank tumour xenolines, they caused seizures, tumour-associated excitotoxicity and shortened survival. Altogether these results thus suggest that high levels of this system contribute to the release of cytotoxic glutamate levels, which promote seizures and act as an autocrine/paracrine signal sustaining tumour growth and invasion ( Lyons et al., 2007 ).

Is astrogliosis a form of epilepsy?

Reactive astrogliosis is present in almost all forms of epilepsy, but it is most notable in presence of hippocampal sclerosis (HS), which is often associated with MTLE and other epilepsy syndromes ( Thom, 2014 ). Indeed, besides a severe loss of principal neurons observed in CA1 and CA3 and granule cell dispersion, HS is characterized by a chronic and fibrillary gliosis in CA1 and radial gliosis in the dentate gyrus, where the length of GFAP + fibres is directly correlated with the degree of cell dispersion in the dentate gyrus ( Fahrner et al., 2007 ). Furthermore, in HS, together with increased conventional GFAP expression, a novel GFAP isoform has been identified in small multinucleate CA1 and CA4 astrocytes, GFAP-γ, which is speculated to regulate astrocyte size and motility ( Martinian et al., 2009 ). Whether HS is a primary cause of epilepsy or the result of repeated epileptic seizures is still controversial. Even if the prevailing view tends to consider HS as a secondary consequence of epilepsy, experimental data on surgical samples and autoptic tissues suggest that HS aetiology is multifactorial. Febrile seizures, genetic susceptibility, alterations of hippocampal development, head injuries, infections and inflammatory and neurodevelopmental factors have indeed been identified as predisposing elements to HS development ( Sendrowski and Sobaniec, 2013, Thom, 2014, Walker, 2015 ).

Where are activated reactive astrocytes located?

In AD brains at early stages of the pathology, activated reactive astrocytes are predominant in the molecular layer of the cerebral cortex and close to amyloid plaques in pyramidal cell layers ( Wisniewski and Wegiel, 1991 ). In several brain regions such as cortex, hippocampus and cerebellum, proliferating processes of hypertrophic astrocytes nearest to amyloid deposits contact and surround the plaques; they penetrate more into non-cored primitive plaques, compared to classic compact cored amyloid deposits, thus merging with them and contributing to their fragmentation, dispersion and the observed variety of plaque morphology ( Kato et al., 1998, Wisniewski and Wegiel, 1991 ). Interestingly, in the visual cortex of AD brains with severe pathology, GFAP-immunoreactive astrocytes and plaques are arranged in a specific laminar distribution: indeed gliosis is preferentially localized in laminae II, III, IVa and IVc, the latter presenting a discrete plaque-associated glyotic horizontal band at the lower edge ( Beach and McGeer, 1988 ). Furthermore, a more recent study has shown that reactive astrocytes together with microglial cells form specific 3D reactive glial nets around plaques in a plaque-specific way: at Aβ dense-core plaques, astrocytic processes are intermingled with microglial cell bodies which envelop the core Aβ structure; while at fibrillary plaques, a higher number of glial cells are recruited to reactive glial net formation and both microglial and astrocytic processes invade the plaque area and interact with Aβ protein ( Bouvier et al., 2016 ).

Is reactive astrogliosis a hallmark of AD?

Reactive astrogliosis is a well-known hallmark of AD, even if its role has not been clearly understood yet. It is identified by an increased expression of GFAP and hypertrophy of astrocytes in the vicinity of amyloid plaques. Post-mortem tissues from AD patients indeed display increased GFAP levels in temporal ( Griffin et al., 1989, Simpson et al., 2010 ), occipital, parietal and frontal lobes ( Kashon et al., 2004 ). Moreover, in the cerebrospinal fluid of AD patients, higher levels of GFAP concentrations have been measured compared to age-matched controls ( Jesse et al., 2009 ). Interestingly, some degree of correlation has been found between GFAP expression and AD progression, with higher GFAP levels at increasing Braak groups ( Simpson et al., 2010) or duration of clinical illness ( Serrano-Pozo et al., 2013 ). However, this correlation remains uncertain, since another work showed no difference in GFAP expression between demented and non-demented brains within the same Braak stage ( Wharton et al., 2009 ). During AD progression, 8 of the 10 different GFAP isoforms described ( Hol and Pekny, 2015) are upregulated. For instance, reactive astrocytes in dentate gyrus subgranular zone, hilus and CA4 area of AD patients display a prominent expression of GFAPδ, but only CA1, CA3 and subiculum astrocytes surrounding plaques showed GFAPδ upregulation with increasing AD stage ( Kamphuis et al., 2014 ). Additionally, the number of human-specific astrocyte subtypes expressing the frame-shifted GFAP variant, GFAP +1, is increased with AD progression, but only few of these GFAP +1 -expressing cells has been identified as associated to plaques, with processes protruding through them ( Kamphuis et al., 2014, Middeldorp et al., 2009 ). Astrogliosis and GFAP upregulation are also accompanied by dysregulation in the expression of other astrocytic cytoskeleton proteins. For instance, in the lateral temporal cortex of advanced AD stages, there is a significant decrease in transcripts encoding members of the myosin and kinesin family and other cytoskeletal proteins, such as actin β, dynein and integrin α. Moreover, transcripts encoding tight junction proteins and adherens junctions are also reduced during AD progression ( Simpson et al., 2011 ). The effect of the altered expression of these genes in astrocytes still remains unclear, but it may affect various intracellular signalling pathways.

What is the most common neurological disorder?

Epilepsy is one of the most prevalent neurological diseases affecting 1% of the world population (World Health Organisation, 2016, http://www.who.int/en/ ). It is characterized by repetitively recurrent seizures, which disrupt normal brain functions and can damage the brain and worsen pre-existing neurological deficits. Contrary to the traditional view assuming that epileptic activity is generated exclusively in and by neurons, an astrocytic basis for epilepsy has been proposed ( Tian et al., 2005 ). Moreover, investigations on specimens from mesial temporal lobe epilepsy (MTLE) patients have identified changes in astrocytic channels and receptors ( Fig. 2 a–b), thus suggesting that astrocyte dysfunction can participate in hyper-excitation, neurotoxicity and seizure spreading, in addition to established neurogenic mechanisms.